Nutritional Restriction and Activity Thermogenesis
These studies will provide us with enormous insight regarding how obese patients adapt energetically during negative energy balance. We will gain fundamental information regarding the metabolic implications of combining food restriction with a walking program compatible to that advocated by statutory agencies. These studies will lead to improved understanding of the energetic adaptation that occurs during negative energy balance and how best to treat patients with obesity.
Status: Completed (Phase 1). Started on June 1st, 2003.
Enrollment: 90 subjects
Study Type: Interventional
Study Design:
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Open Label
- Primary Purpose: Diagnostic
Conditions:
Interventions:
- Behavioral: Exercise and behavior modification
Eligibility
Ninety sedentary subjects, aged 25-55, who live <10 miles from Rochester will be recruited. This age range has been selected to enable us to study individuals at the peak age-range of obesity and over-weight prevalence and to avoid issues of menopause. Subjects will not be eligible for consideration if they take two or more bouts of exercise/week or participate in sports for more than 2 hours/week. Subjects with predicted weight maintenance energy requirements of <2000 kcal/day will have been excluded at screening. This is because when we come to underfeeding by 1000 kcal/day, we want to avoid feeding any volunteer <1000 kcal/day, for safety & compliance reasons.
(A) LEAN: 30 (15F,15M) lean subjects; BMI <25 kg/m2. Each lean subject will be individually matched for height (+3cm) and age (+3 years) to an obese subject so as to establish comparable groupings for body size. Subjects will have been weight-stable for six months (B) OBESE: 30 (15F,15M) obese subjects; BMI 30-35 kg/m2. Subjects will have been weight-stable for six months (C) POST-OBESE: 30 (15F,15M) patients will have had a previous BMI >30 kg/m2 and a weight loss sufficient to achieve a BMI of <26 kg/m2 maintained for at least 2 months (with weight fluctuation during this period of <1 kg) (94). We will attempt to match these subjects to the obese subjects as described above.
- Gender
Both
- Mininum Age
25 Years
- Maximum Age
55 Years
- Healthy Volunteers
Accepts Healthy Volunteers
Resources
Source: Mayo Clinic
Authority: United States: Federal Government
Locations
-
Mayo Clinic
Rochester
Minnesota
55905
United States
Officials
James A Levine, M.D., Ph.D. (Principal Investigator, Mayo Clinic)
Sponsors
Mayo Clinic (Lead Sponsor)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Collaborator)
References
None.
Links
None.
- Date Verified
- April 1st, 2011
- First Received
- April 1st, 2011
- Last Changed
- April 1st, 2011
Information obtained from ClinicalTrials.gov on June 09, 2011. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.
